Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&AQ pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Your responsibilities : Fair marketing & brand experience Serve as the global owner of fair marketing and experiential initiatives, shaping frameworks, prioritisation, final sign-off for integrated campaigns across all Art Basel shows with clear cultural brand